Belimumab in Lupus Nephritis Belimumab is a BLyS-specific inhibitor that is FDA approved for the treatment of active l
Tweet Content
Belimumab in Lupus Nephritis
Belimumab is a BLyS-specific inhibitor that is FDA approved for the treatment of active lupus and lupus nephritis, based on a few pivotal trials; and now a metanalysis supports its use in active lupus nephritis.
https://t.co/f2odJWlyR2 https://t.co/y5exJIFzht
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off